You are here:

Home
NICE Guidance
Conditions and diseases
Gynaecological conditions
Ovarian cancer

Ovarian cancer Products

A list of all our products on ovarian cancer

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceDiagnostics guidanceInterventional procedures guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisation

New and updated

New and updatedNew in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Mirvetuximab soravtansine for treating folate receptor alpha-positive platinum-resistant advanced epithelial ovarian, fallopian tube or primary peritoneal cancer [ID6442]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
17 December 2025
Expected publication date:
12 March 2026